Zahi Touma, MD, PhD, from the University Health Network in Toronto, and colleagues examined whether anifrolumab plus SOC is associated with reduced organ damage accumulation compared with SOC only ...
Hosted on MSN1mon
Anifrolumab Tied to Less Organ Damage for Patients With LupusT HURSDAY, Feb. 20, 2025 (HealthDay News) -- For patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with less organ damage after 208 weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback